[
  {
    "ts": null,
    "headline": "Why Boston Scientific (BSX) Stock Is Up Today",
    "summary": "Shares of medical device company Boston Scientific (NYSE:BSX) jumped 8.5% in the pre-market session after the company reported first quarter 2025 results that beat analysts' sales and EPS expectations. Organic sales growth topped the company's own forecast and was led by a 25.6% surge in its Cardiovascular segment, a signal that demand in its largest business is accelerating. Looking ahead, its revenue guidance for next quarter exceeded Wall Street's estimates. Overall, we think this was a decen",
    "url": "https://finnhub.io/api/news?id=5ca837e9917fabdb460e7781698840b955b3f6e5cf075ba1d5c0d7846424e88f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745430245,
      "headline": "Why Boston Scientific (BSX) Stock Is Up Today",
      "id": 134046518,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Shares of medical device company Boston Scientific (NYSE:BSX) jumped 8.5% in the pre-market session after the company reported first quarter 2025 results that beat analysts' sales and EPS expectations. Organic sales growth topped the company's own forecast and was led by a 25.6% surge in its Cardiovascular segment, a signal that demand in its largest business is accelerating. Looking ahead, its revenue guidance for next quarter exceeded Wall Street's estimates. Overall, we think this was a decen",
      "url": "https://finnhub.io/api/news?id=5ca837e9917fabdb460e7781698840b955b3f6e5cf075ba1d5c0d7846424e88f"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
    "summary": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=29a8eec66add81cb87ce24f7c99681234cae07dab3748a84c3c3de9f758ce3b9",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745426100,
      "headline": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
      "id": 134054767,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=29a8eec66add81cb87ce24f7c99681234cae07dab3748a84c3c3de9f758ce3b9"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Raises Full-Year Outlook Following First-Quarter Beat, Names New CFO",
    "summary": "Boston Scientific (BSX) raised its financial guidance for 2025 after the medical device manufacturer",
    "url": "https://finnhub.io/api/news?id=e522f7799ceb2f3e8c7ce534a64221b2dc5c0e4a723bd41c9e9455a7cb74eebc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745424477,
      "headline": "Boston Scientific Raises Full-Year Outlook Following First-Quarter Beat, Names New CFO",
      "id": 134046519,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (BSX) raised its financial guidance for 2025 after the medical device manufacturer",
      "url": "https://finnhub.io/api/news?id=e522f7799ceb2f3e8c7ce534a64221b2dc5c0e4a723bd41c9e9455a7cb74eebc"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Jets Higher As Cardio Sales Pump Up First-Quarter Beat",
    "summary": "Boston Scientific Jets Higher As Cardio Sales Pump Up First-Quarter Beat",
    "url": "https://finnhub.io/api/news?id=906a8e443711a6bae97d76b5e0c745259071968f7e494c8f43c4c67d33fb63eb",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745424465,
      "headline": "Boston Scientific Jets Higher As Cardio Sales Pump Up First-Quarter Beat",
      "id": 134054744,
      "image": "",
      "related": "BSX",
      "source": "DowJones",
      "summary": "Boston Scientific Jets Higher As Cardio Sales Pump Up First-Quarter Beat",
      "url": "https://finnhub.io/api/news?id=906a8e443711a6bae97d76b5e0c745259071968f7e494c8f43c4c67d33fb63eb"
    }
  },
  {
    "ts": null,
    "headline": "Field Medical raises $40M for PFA in ventricular tachycardia",
    "summary": "Led by Farapulse founder Steven Mickelsen, Field has developed a pulsed field ablation device to tackle the dangerous heart rhythm disorder.",
    "url": "https://finnhub.io/api/news?id=a819e3900b7db3de32896180deb8b0f27a773f71c6a52eae8893341206eb6aef",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745420400,
      "headline": "Field Medical raises $40M for PFA in ventricular tachycardia",
      "id": 134059511,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Led by Farapulse founder Steven Mickelsen, Field has developed a pulsed field ablation device to tackle the dangerous heart rhythm disorder.",
      "url": "https://finnhub.io/api/news?id=a819e3900b7db3de32896180deb8b0f27a773f71c6a52eae8893341206eb6aef"
    }
  },
  {
    "ts": null,
    "headline": "Is Boston Scientific Corp. (NYSE:BSX) the Best Stock Under $100 to Buy According to Hedge Funds?",
    "summary": "We recently published a list of the 12 Best Stocks Under $100 to Buy According to Hedge Funds. In this article, we are going to take a look at where Boston Scientific Corp. (NYSE:BSX) stands against other stocks under $100 to buy according to hedge funds. On April 21, Chris Davis of Davis Advisors appeared […]",
    "url": "https://finnhub.io/api/news?id=c08d10eda2fe3db820f2606f666c8753ad3e47043c3d0a10dcbb07c5f0ef4687",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745418499,
      "headline": "Is Boston Scientific Corp. (NYSE:BSX) the Best Stock Under $100 to Buy According to Hedge Funds?",
      "id": 134046520,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "We recently published a list of the 12 Best Stocks Under $100 to Buy According to Hedge Funds. In this article, we are going to take a look at where Boston Scientific Corp. (NYSE:BSX) stands against other stocks under $100 to buy according to hedge funds. On April 21, Chris Davis of Davis Advisors appeared […]",
      "url": "https://finnhub.io/api/news?id=c08d10eda2fe3db820f2606f666c8753ad3e47043c3d0a10dcbb07c5f0ef4687"
    }
  },
  {
    "ts": null,
    "headline": "BSX Q1 Earnings & Revenues Beat, Stock Up, 2025 View Raised",
    "summary": "Boston Scientific's first-quarter 2025 performance benefits from the strength of its product portfolio.",
    "url": "https://finnhub.io/api/news?id=38b77ebeb92f5a06db4aa35b9c05cacc0fc8d9d2a604b32db57f628d6b778312",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745416020,
      "headline": "BSX Q1 Earnings & Revenues Beat, Stock Up, 2025 View Raised",
      "id": 134046521,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific's first-quarter 2025 performance benefits from the strength of its product portfolio.",
      "url": "https://finnhub.io/api/news?id=38b77ebeb92f5a06db4aa35b9c05cacc0fc8d9d2a604b32db57f628d6b778312"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Stock Surges on Strong Results, Outlook; CFO To Retire",
    "summary": "Shares of Boston Scientific rose sharply Wednesday after the firm posted better-than-expected quarterly results.",
    "url": "https://finnhub.io/api/news?id=cd85e843507e7ea5a3739f15cdc14876784ca66d313486b8cdeb75baa98a0c9a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745415311,
      "headline": "Boston Scientific Stock Surges on Strong Results, Outlook; CFO To Retire",
      "id": 134046522,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Shares of Boston Scientific rose sharply Wednesday after the firm posted better-than-expected quarterly results.",
      "url": "https://finnhub.io/api/news?id=cd85e843507e7ea5a3739f15cdc14876784ca66d313486b8cdeb75baa98a0c9a"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific (BSX) Reports Q1 Earnings: What Key Metrics Have to Say",
    "summary": "The headline numbers for Boston Scientific (BSX) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
    "url": "https://finnhub.io/api/news?id=ede17b8cd1c18077af650f4492db5bf5d5d469793777ea3c14d48b85f7d01626",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745415025,
      "headline": "Boston Scientific (BSX) Reports Q1 Earnings: What Key Metrics Have to Say",
      "id": 134046523,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The headline numbers for Boston Scientific (BSX) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
      "url": "https://finnhub.io/api/news?id=ede17b8cd1c18077af650f4492db5bf5d5d469793777ea3c14d48b85f7d01626"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific is ‘very bullish’ on 2025 despite $200M tariff hit",
    "summary": "The company joins Johnson & Johnson and Abbott as top medtech firms that expect an impact in the hundreds of millions of dollars from President Donald Trump’s tariff policies.",
    "url": "https://finnhub.io/api/news?id=b01afb57f6504c3c50e5282b668435e581a2752899f59ef601cd56f2f976fdeb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745409540,
      "headline": "Boston Scientific is ‘very bullish’ on 2025 despite $200M tariff hit",
      "id": 134046525,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The company joins Johnson & Johnson and Abbott as top medtech firms that expect an impact in the hundreds of millions of dollars from President Donald Trump’s tariff policies.",
      "url": "https://finnhub.io/api/news?id=b01afb57f6504c3c50e5282b668435e581a2752899f59ef601cd56f2f976fdeb"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific (BSX) Q1 Earnings and Revenues Top Estimates",
    "summary": "Boston Scientific (BSX) delivered earnings and revenue surprises of 11.94% and 2.31%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=a817a54f38abbbe20e61cdbacb59d0967b01979ff0d1b802ca3afb7c1af2cd68",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745408404,
      "headline": "Boston Scientific (BSX) Q1 Earnings and Revenues Top Estimates",
      "id": 134046526,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (BSX) delivered earnings and revenue surprises of 11.94% and 2.31%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=a817a54f38abbbe20e61cdbacb59d0967b01979ff0d1b802ca3afb7c1af2cd68"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corporation (BSX) Q1 2025 Earnings Call Transcript",
    "summary": "Boston Scientific Corporation (BSX) Q1 2025 Earnings Call Transcript",
    "url": "https://finnhub.io/api/news?id=086c6bd4c280448fb47f77a678edbb94b9b7bfaa319f4a1d605a4c2cfb8fa0a2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745408045,
      "headline": "Boston Scientific Corporation (BSX) Q1 2025 Earnings Call Transcript",
      "id": 134044846,
      "image": "",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=086c6bd4c280448fb47f77a678edbb94b9b7bfaa319f4a1d605a4c2cfb8fa0a2"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific shares rise on strong Q1 results, raised EPS guidance",
    "summary": "Investing.com -- Boston Scientific Corporation reported first-quarter earnings and revenue that surpassed analyst expectations, driving shares up 3.2% in early trading Wednesday.",
    "url": "https://finnhub.io/api/news?id=cb22341e66ad7e94041f947272d8d002f62dae601d7238d213e044c8436e19b6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745406731,
      "headline": "Boston Scientific shares rise on strong Q1 results, raised EPS guidance",
      "id": 134046527,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Investing.com -- Boston Scientific Corporation reported first-quarter earnings and revenue that surpassed analyst expectations, driving shares up 3.2% in early trading Wednesday.",
      "url": "https://finnhub.io/api/news?id=cb22341e66ad7e94041f947272d8d002f62dae601d7238d213e044c8436e19b6"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Chief Financial Officer (CFO) Dan Brennan to retire; Jon Monson, senior vice president, Investor Relations to succeed Brennan",
    "summary": "Boston Scientific Corporation (NYSE: BSX) today announced that Dan Brennan, executive vice president and chief financial officer, has elected to retire following nearly 30 successful years with the company. Brennan will transition out of the chief financial officer position at the end of June and is expected to remain with Boston Scientific as a senior advisor through early October 2025.",
    "url": "https://finnhub.io/api/news?id=0565e73fb3fbc65e34d49422bf0f55eb69c9eae89c8585f3616dcd2f4ca77a03",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745405100,
      "headline": "Boston Scientific Chief Financial Officer (CFO) Dan Brennan to retire; Jon Monson, senior vice president, Investor Relations to succeed Brennan",
      "id": 134046528,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific Corporation (NYSE: BSX) today announced that Dan Brennan, executive vice president and chief financial officer, has elected to retire following nearly 30 successful years with the company. Brennan will transition out of the chief financial officer position at the end of June and is expected to remain with Boston Scientific as a senior advisor through early October 2025.",
      "url": "https://finnhub.io/api/news?id=0565e73fb3fbc65e34d49422bf0f55eb69c9eae89c8585f3616dcd2f4ca77a03"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific (NYSE:BSX) Beats Q1 Sales Targets, Next Quarter’s Sales Guidance is Optimistic",
    "summary": "Medical device company Boston Scientific (NYSE:BSX) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 20.9% year on year to $4.66 billion. Guidance for next quarter’s revenue was better than expected at $4.88 billion at the midpoint, 2% above analysts’ estimates. Its non-GAAP profit of $0.75 per share was 11.5% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=411bf3278454086b1f309b304cd38395742b13b95491d01dec015570b7aa83b3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745404784,
      "headline": "Boston Scientific (NYSE:BSX) Beats Q1 Sales Targets, Next Quarter’s Sales Guidance is Optimistic",
      "id": 134046529,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Medical device company Boston Scientific (NYSE:BSX) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 20.9% year on year to $4.66 billion. Guidance for next quarter’s revenue was better than expected at $4.88 billion at the midpoint, 2% above analysts’ estimates. Its non-GAAP profit of $0.75 per share was 11.5% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=411bf3278454086b1f309b304cd38395742b13b95491d01dec015570b7aa83b3"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific: Q1 Earnings Snapshot",
    "summary": "The results surpassed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of 67 cents per share. The medical device manufacturer posted revenue of $4.66 billion in the period, also topping Street forecasts.",
    "url": "https://finnhub.io/api/news?id=3f4b4bbe460d62ad329a9b33ff7841e005d9874be53d8b5cbd1bdeced3c9bf97",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745404742,
      "headline": "Boston Scientific: Q1 Earnings Snapshot",
      "id": 134046530,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The results surpassed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of 67 cents per share. The medical device manufacturer posted revenue of $4.66 billion in the period, also topping Street forecasts.",
      "url": "https://finnhub.io/api/news?id=3f4b4bbe460d62ad329a9b33ff7841e005d9874be53d8b5cbd1bdeced3c9bf97"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific announces results for first quarter 2025",
    "summary": "Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.663 billion during the first quarter of 2025, growing 20.9 percent on a reported basis, 22.2 percent on an operational1 basis and 18.2 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net income attributable to Boston Scientific common stockholders of $674 million or $0.45 per share (EPS), compared to $495 million or $0.33 per share a year ago, and achieved adjusted3 EPS of $0.75 for",
    "url": "https://finnhub.io/api/news?id=f3c89ab443a3d789b41f7903fa7bac4cfa9de5c17f2ca2010c89d3850ff1c0ce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745404200,
      "headline": "Boston Scientific announces results for first quarter 2025",
      "id": 134046531,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.663 billion during the first quarter of 2025, growing 20.9 percent on a reported basis, 22.2 percent on an operational1 basis and 18.2 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net income attributable to Boston Scientific common stockholders of $674 million or $0.45 per share (EPS), compared to $495 million or $0.33 per share a year ago, and achieved adjusted3 EPS of $0.75 for",
      "url": "https://finnhub.io/api/news?id=f3c89ab443a3d789b41f7903fa7bac4cfa9de5c17f2ca2010c89d3850ff1c0ce"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Shares Higher on Rosy Outlook, 1Q Beats",
    "summary": "By Adriano Marchese Boston Scientific shares rose in premarket trading Wednesday after it set expectations for strong growth for the full year and the second quarter after topping expectations in...",
    "url": "https://finnhub.io/api/news?id=6892b8a3ecae424846ebb41352a51ee055637614dad5592bbf5b1bdfd3718e3d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745396227,
      "headline": "Boston Scientific Shares Higher on Rosy Outlook, 1Q Beats",
      "id": 134043462,
      "image": "",
      "related": "BSX",
      "source": "Finnhub",
      "summary": "By Adriano Marchese Boston Scientific shares rose in premarket trading Wednesday after it set expectations for strong growth for the full year and the second quarter after topping expectations in...",
      "url": "https://finnhub.io/api/news?id=6892b8a3ecae424846ebb41352a51ee055637614dad5592bbf5b1bdfd3718e3d"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific : Q1 2025 Financial and Operational Highlights",
    "summary": "Q1 2025 Highlights April 23, 2025 Q1 2025 Financial & Operational Highlights | April 23, 2025 ...",
    "url": "https://finnhub.io/api/news?id=8b1d5b3f9bd25656753e7594e6c828728d7432bb13017dd0f21a76a9286d36cc",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745392554,
      "headline": "Boston Scientific : Q1 2025 Financial and Operational Highlights",
      "id": 134043046,
      "image": "",
      "related": "BSX",
      "source": "Finnhub",
      "summary": "Q1 2025 Highlights April 23, 2025 Q1 2025 Financial & Operational Highlights | April 23, 2025 ...",
      "url": "https://finnhub.io/api/news?id=8b1d5b3f9bd25656753e7594e6c828728d7432bb13017dd0f21a76a9286d36cc"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Names Jon Monson Finance Chief as Dan Brennan Retires",
    "summary": "By Colin Kellaher Boston Scientific's top finance executive, Dan Brennan, is retiring after nearly three decades with the medical-technology company. Boston Scientific on Wednesday said Jon...",
    "url": "https://finnhub.io/api/news?id=358da1b1f027d0206e9cbe072f58b97a4bdec8ebbac03f8344972c548758d046",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745392507,
      "headline": "Boston Scientific Names Jon Monson Finance Chief as Dan Brennan Retires",
      "id": 134043007,
      "image": "",
      "related": "BSX",
      "source": "Finnhub",
      "summary": "By Colin Kellaher Boston Scientific's top finance executive, Dan Brennan, is retiring after nearly three decades with the medical-technology company. Boston Scientific on Wednesday said Jon...",
      "url": "https://finnhub.io/api/news?id=358da1b1f027d0206e9cbe072f58b97a4bdec8ebbac03f8344972c548758d046"
    }
  }
]